Tech Company Financing Transactions

insitro Funding Round

Canada Pension Plan Investment Board, Alexandria Venture Investments and Andreessen Horowitz participated in a $400 million Series C capital raise for insitro. The round was recorded on 3/16/2021.

Transaction Overview

Company Name
Announced On
3/16/2021
Transaction Type
Venture Equity
Amount
$400,000,000
Round
Series C
Investors

Canada Pension Plan Investment Board (Lead Investor) (Paul McCracken)

Alexandria Venture Investments

Andreessen Horowitz (Vijay Pande)

Arch Venture Partners

BlackRock

Casdin Capital

Foresite Capital

GV

HOF Capital

SoftBank Vision Fund

T. Rowe Price (Jay Markowitz)

Temasek Holdings

Third Rock Ventures

Two Sigma Ventures

Proceeds Purpose
Proceeds from the financing will be used to further expand insitro's platform capabilities and pipeline, providing resources to access enabling datasets, enabling or complementary technologies and platforms, and potential in-licensed assets that have been de-risked by the company's unique approach to target and patient biomarker discovery.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
279 East Grand Ave. 200
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology.
Profile
insitro LinkedIn Company Profile
Social Media
insitro Company Twitter Account
Company News
insitro News
Facebook
insitro on Facebook
YouTube
insitro on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daphne Koller
  Daphne Koller LinkedIn Profile  Daphne Koller Twitter Account  Daphne Koller News  Daphne Koller on Facebook
Chief Financial Officer
Mary Rozenman
  Mary Rozenman LinkedIn Profile  Mary Rozenman Twitter Account  Mary Rozenman News  Mary Rozenman on Facebook
Chief Technical Officer
Ajamete Kaykas
  Ajamete Kaykas LinkedIn Profile  Ajamete Kaykas Twitter Account  Ajamete Kaykas News  Ajamete Kaykas on Facebook
Vice President
Matthew Albert
  Matthew Albert LinkedIn Profile  Matthew Albert Twitter Account  Matthew Albert News  Matthew Albert on Facebook
Vice President
Keith James
  Keith James LinkedIn Profile  Keith James Twitter Account  Keith James News  Keith James on Facebook
Vice President
Matthew Rasmussen
  Matthew Rasmussen LinkedIn Profile  Matthew Rasmussen Twitter Account  Matthew Rasmussen News  Matthew Rasmussen on Facebook
VP - Bus. Development
Perry Palmedo
  Perry Palmedo LinkedIn Profile  Perry Palmedo Twitter Account  Perry Palmedo News  Perry Palmedo on Facebook
VP - Engineering
John Cesarek
  John Cesarek LinkedIn Profile  John Cesarek Twitter Account  John Cesarek News  John Cesarek on Facebook
VP - Finance
Allison Lai
  Allison Lai LinkedIn Profile  Allison Lai Twitter Account  Allison Lai News  Allison Lai on Facebook
VP - General Counsel
Duane Valz
  Duane Valz LinkedIn Profile  Duane Valz Twitter Account  Duane Valz News  Duane Valz on Facebook
VP - Human Resources
Britt Huber
  Britt Huber LinkedIn Profile  Britt Huber Twitter Account  Britt Huber News  Britt Huber on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/16/2021: Datagen venture capital transaction
Next: 3/16/2021: Nano Cures venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary